{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:38:18Z","timestamp":1787006298309,"version":"build-2736575974"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T00:00:00Z","timestamp":1637193600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011045","name":"French Government Ministry of Higher Education and Research and Innovation","doi-asserted-by":"publisher","award":["PHRC-K15-189"],"award-info":[{"award-number":["PHRC-K15-189"]}],"id":[{"id":"10.13039\/501100011045","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.ctro.2021.11.007","type":"journal-article","created":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T12:02:17Z","timestamp":1637928137000},"page":"59-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Meta-analysis of chemotherapy in nasopharynx carcinoma (MAC-NPC): An update on 26 trials and 7080 patients"],"prefix":"10.1016","volume":"32","author":[{"given":"Pierre","family":"Blanchard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne W.M.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Carmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ng","family":"Wai Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony T.C.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruey Long","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Fei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Yu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dora L.W.","family":"Kwong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon S.X.","family":"Poh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Ngan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Qiang","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Ollivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Fountzilas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Bourhis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Aup\u00e9rin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Lacas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Pignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Aup\u00e9rin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Blanchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Benhamou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Bourhis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Carmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somvilai","family":"Chakrabandhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"TC Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu-Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J","family":"Chappell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horace","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"TT Chua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melvin","family":"Lee Kiang Chua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Fountzilas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Huang","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruey-Long","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Yu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Pun Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.F.","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Angeliki Koliou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dora","family":"LW Kwong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Lacas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Chuan","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka","family":"On Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L","family":"LeBlanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"WM Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho","family":"Fun Victor Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Fei Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigette","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Qiang","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frankie","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai","family":"Tong Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Ngan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Ollivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"O'Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Petit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Pierre Pignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon X.","family":"Poh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerta","family":"R\u00fccker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Sham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoke","family":"Lim Soong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-Quan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuk","family":"Tung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Wee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guopei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctro.2021.11.007_b0005","unstructured":"Ferlay J, Ervik M, Lam F, et al: Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. [Internet][cited 2019 Sep 23] Available from: https:\/\/gco.iarc.fr\/today, accessed."},{"issue":"10192","key":"10.1016\/j.ctro.2021.11.007_b0010","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","article-title":"Nasopharyngeal carcinoma","volume":"394","author":"Chen","year":"2019","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ctro.2021.11.007_b0015","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S1470-2045(15)70126-9","article-title":"Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis","volume":"16","author":"Blanchard","year":"2015","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.ctro.2021.11.007_b0020","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1200\/JCO.2016.67.4119","article-title":"What Is the Best Treatment of Locally Advanced Nasopharyngeal Carcinoma? An Individual Patient Data Network Meta-Analysis","volume":"35","author":"Ribassin-Majed","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctro.2021.11.007_b0025","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/S1470-2045(16)30410-7","article-title":"Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial","volume":"17","author":"Sun","year":"2016","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2021.11.007_b0030","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/annonc\/mdx770","article-title":"A randomized trial of induction docetaxel\u2013cisplatin\u20135FU followed by concomitant cisplatin-RT versus concomitant cisplatin-RT in nasopharyngeal carcinoma (GORTEC 2006\u201302)","volume":"29","author":"Frikha","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ctro.2021.11.007_b0035","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1056\/NEJMoa1905287","article-title":"Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma","volume":"381","author":"Zhang","year":"2019","journal-title":"N Engl J Med"},{"issue":"31","key":"10.1016\/j.ctro.2021.11.007_b0040","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1200\/JCO.2018.77.7847","article-title":"Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial","volume":"36","author":"Chan","year":"2018","journal-title":"JCO"},{"issue":"19","key":"10.1016\/j.ctro.2021.11.007_b0045","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1002\/sim.4780141902","article-title":"Practical methodology of meta-analyses (overviews) using updated individual patient data: Cochrane Working Group","volume":"14","author":"Stewart","year":"1995","journal-title":"Stat Med"},{"issue":"4","key":"10.1016\/j.ctro.2021.11.007_b0050","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0197-2456(96)00075-X","article-title":"A note on quantifying follow-up in studies of failure time","volume":"17","author":"Schemper","year":"1996","journal-title":"Control Clin Trials"},{"issue":"5","key":"10.1016\/j.ctro.2021.11.007_b0055","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0033-0620(85)80003-7","article-title":"Beta blockade during and after myocardial infarction: an overview of the randomized trials","volume":"27","author":"Yusuf","year":"1985","journal-title":"Prog Cardiovasc Dis"},{"issue":"8842","key":"10.1016\/j.ctro.2021.11.007_b0060","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/0140-6736(93)93004-K","article-title":"Meta-analysis of the literature or of individual patient data: is there a difference?","volume":"341","author":"Stewart","year":"1993","journal-title":"Lancet"},{"issue":"446","key":"10.1016\/j.ctro.2021.11.007_b0065","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A Proportional Hazards Model for the Subdistribution of a Competing Risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.ctro.2021.11.007_b0070","doi-asserted-by":"crossref","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group: Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 339:1\u201315, 1992.","DOI":"10.1016\/0140-6736(92)90139-T"},{"issue":"11","key":"10.1016\/j.ctro.2021.11.007_b0075","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"issue":"9","key":"10.1016\/j.ctro.2021.11.007_b0080","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jclinepi.2010.11.016","article-title":"A critical review of methods for the assessment of patient-level interactions in individual participant data meta-analysis of randomized trials, and guidance for practitioners","volume":"64","author":"Fisher","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ctro.2021.11.007_b0085","doi-asserted-by":"crossref","unstructured":"Non-small Cell Lung Cancer Collaborative Group: Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. British medical journal 311:899\u2013909, 1995.","DOI":"10.1136\/bmj.311.7010.899"},{"key":"10.1016\/j.ctro.2021.11.007_b0090","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/j.ejca.2015.06.009","article-title":"OP0005 Neoadjuvant chemotherapy plus chemoradiation (NACT-CCRT) versus chemoradiation plus adjuvant chemotherapy (CCRT-ACT) for locally advanced nasopharyngeal cancer: 3-Year results from a randomised trial","volume":"51","author":"Chakrabandhu","year":"2015","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.ctro.2021.11.007_b0095","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0360-3016(95)00218-N","article-title":"A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma","volume":"33","author":"Chan","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ctro.2021.11.007_b0100","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.ijrobp.2015.01.002","article-title":"Concurrent chemo-radiation with or without induction gemcitabine, Carboplatin, and Paclitaxel: a randomized, phase 2\/3 trial in locally advanced nasopharyngeal carcinoma","volume":"91","author":"Tan","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"13","key":"10.1016\/j.ctro.2021.11.007_b0105","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1200\/JCO.2004.05.173","article-title":"Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: A factorial study","volume":"22","author":"Kwong","year":"2004","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2021.11.007_b0110","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.radonc.2010.09.023","article-title":"A randomized trial on addition of concurrent-adjuvant chemotherapy and\/or accelerated fractionation for locally-advanced nasopharyngeal carcinoma","volume":"98","author":"Lee","year":"2011","journal-title":"Radiother Oncol"},{"issue":"13","key":"10.1016\/j.ctro.2021.11.007_b0115","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/j.ejca.2015.05.025","article-title":"Ten-year outcomes of a randomised trial for locoregionally advanced nasopharyngeal carcinoma: A single-institution experience from an endemic area","volume":"51","author":"Huang","year":"2015","journal-title":"Eur J Cancer"},{"issue":"15_suppl","key":"10.1016\/j.ctro.2021.11.007_b0120","doi-asserted-by":"crossref","first-page":"6056","DOI":"10.1200\/jco.2008.26.15_suppl.6056","article-title":"Long-term results of concurrent and adjuvant chemotherapy for advanced nasopharyngeal carcinoma","volume":"26","author":"Kwong","year":"2008","journal-title":"JCO"},{"key":"10.1016\/j.ctro.2021.11.007_b0125","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ejca.2017.01.002","article-title":"Adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: Long-term results of a phase 3 multicentre randomised controlled trial","volume":"75","author":"Chen","year":"2017","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.ctro.2021.11.007_b0130","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1200\/JCO.1998.16.4.1310","article-title":"Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099","volume":"16","author":"Al-Sarraf","year":"1998","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.ctro.2021.11.007_b0135","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S0360-3016(01)02781-X","article-title":"A phase III study of adjuvant chemotherapy in advanced nasopharyngeal carcinoma patients","volume":"52","author":"Chi","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"10.1016\/j.ctro.2021.11.007_b0140","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/jnci\/dji084","article-title":"Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma","volume":"97","author":"Chan","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"27","key":"10.1016\/j.ctro.2021.11.007_b0145","doi-asserted-by":"crossref","first-page":"6730","DOI":"10.1200\/JCO.2005.16.790","article-title":"Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer\/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety","volume":"23","author":"Wee","year":"2005","journal-title":"J Clin Oncol"},{"issue":"15","key":"10.1016\/j.ctro.2021.11.007_b0150","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1093\/jnci\/djq258","article-title":"Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma","volume":"102","author":"Lee","year":"2010","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.ctro.2021.11.007_b0155","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/annonc\/mdr116","volume":"23","author":"Fountzilas","year":"2012","journal-title":"Ann Oncol"},{"issue":"8","key":"10.1016\/j.ctro.2021.11.007_b0160","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/annonc\/mdt163","article-title":"Long-term follow-up of a phase III study comparing radiotherapy with or without weekly oxaliplatin for locoregionally advanced nasopharyngeal carcinoma","volume":"24","author":"Wu","year":"2013","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.ctro.2021.11.007_b0165","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.oraloncology.2012.04.006","article-title":"A randomized trial of induction chemotherapy plus concurrent chemoradiotherapy versus induction chemotherapy plus radiotherapy for locoregionally advanced nasopharyngeal carcinoma","volume":"48","author":"Huang","year":"2012","journal-title":"Oral Oncol"},{"issue":"23","key":"10.1016\/j.ctro.2021.11.007_b0170","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1093\/jnci\/djr432","article-title":"Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial","volume":"103","author":"Chen","year":"2011","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"10.1016\/j.ctro.2021.11.007_b0175","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1093\/annonc\/mdy249","volume":"29","author":"Hong","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ctro.2021.11.007_b0180","doi-asserted-by":"crossref","unstructured":"International Nasopharynx Cancer Study Group, VUMCA I Trial: Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV(> or = N2, M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progression-free survival. Int J Radiat Oncol Biol Phys 35:463\u2013469, 1996.","DOI":"10.1016\/S0360-3016(96)80007-1"},{"key":"10.1016\/j.ctro.2021.11.007_b0185","unstructured":"NCCN Guidelines - Head and Neck Cancers - 2021 [Internet][cited 2021 Jul 21] Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/head-and-neck.pdf."},{"issue":"7","key":"10.1016\/j.ctro.2021.11.007_b0190","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1200\/JCO.20.03237","article-title":"Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline","volume":"39","author":"Chen","year":"2021","journal-title":"JCO"},{"key":"10.1016\/j.ctro.2021.11.007_b0195","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S1470-2045(17)30458-8","article-title":"Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis","volume":"18","author":"Lacas","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctro.2021.11.007_b0200","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.radonc.2021.01.013","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group","volume":"156","author":"Lacas","year":"2021","journal-title":"Radiother Oncol"},{"issue":"8","key":"10.1016\/j.ctro.2021.11.007_b0205","doi-asserted-by":"crossref","first-page":"e020499","DOI":"10.1136\/bmjopen-2017-020499","article-title":"Impact of missing individual patient data on 18 meta-analyses of randomised trials in oncology: Gustave Roussy experience","volume":"8","author":"Fayard","year":"2018","journal-title":"BMJ Open"},{"issue":"16","key":"10.1016\/j.ctro.2021.11.007_b0210","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1002\/cncr.32972","article-title":"NPC-0501 trial on the value of changing chemoradiotherapy sequence, replacing 5-fluorouracil with capecitabine, and altering fractionation for patients with advanced nasopharyngeal carcinoma","volume":"126","author":"Lee","year":"2020","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.ctro.2021.11.007_b0215","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/S1470-2045(21)00302-8","article-title":"Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial","volume":"22","author":"Yang","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctro.2021.11.007_b0220","unstructured":"Rui-hua Xu H-QM, Sun Yat-sen University Cancer Center SKL of O in SC, Department of Nasopharyngeal Carcinoma SYUCC, et al: JUPITER-02: Randomized, double-blind, phase III study of toripalimab or placebo plus gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (NPC). [Internet][cited 2021 Jun 28] Available from: https:\/\/meetinglibrary.asco.org\/record\/196620\/abstract."},{"issue":"4","key":"10.1016\/j.ctro.2021.11.007_b0225","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S1470-2045(20)30737-3","article-title":"Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial","volume":"22","author":"Lee","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctro.2021.11.007_b0230","doi-asserted-by":"crossref","unstructured":"Yuan C, Xu X-H, Luo S-W, et al: Which neoadjuvant chemotherapy regimen should be recommended for patients with advanced nasopharyngeal carcinoma?: A network meta-analysis. Medicine (Baltimore) 97:e11978, 2018.","DOI":"10.1097\/MD.0000000000011978"},{"key":"10.1016\/j.ctro.2021.11.007_b0235","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.2147\/OTT.S193039","article-title":"Combination treatment with cetuximab in advanced nasopharyngeal carcinoma patients: a meta-analysis","volume":"12","author":"Shen","year":"2019","journal-title":"ONCOTARGETS AND THERAPY"},{"issue":"1","key":"10.1016\/j.ctro.2021.11.007_b0240","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.radonc.2018.02.027","article-title":"Induction chemotherapy for locally advanced nasopharyngeal carcinoma treated with concurrent chemoradiation: A systematic review and meta-analysis","volume":"129","author":"Tan","year":"2018","journal-title":"Radiother Oncol"},{"issue":"10","key":"10.1016\/j.ctro.2021.11.007_b0245","doi-asserted-by":"crossref","first-page":"e1913619","DOI":"10.1001\/jamanetworkopen.2019.13619","article-title":"Association of Chemoradiotherapy Regimens and Survival Among Patients With Nasopharyngeal Carcinoma: A Systematic Review and Meta-analysis","volume":"2","author":"Zhang","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"5","key":"10.1016\/j.ctro.2021.11.007_b0250","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0360-3016(00)01522-4","article-title":"Patterns of failure after induction chemotherapy and radiotherapy for locoregionally advanced nasopharyngeal carcinoma: the Queen Mary Hospital experience","volume":"49","author":"Chua","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2021.11.007_b0255","first-page":"463","volume":"35","author":"Cvitkovic","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"10.1016\/j.ctro.2021.11.007_b0260","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1002\/cncr.10473","article-title":"A prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma","volume":"94","author":"Hareyama","year":"2002","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.ctro.2021.11.007_b0265","first-page":"1904","article-title":"Sensorineural Hearing Loss After Radiotherapy and Chemoradiotherapy: A Single, Blinded","volume":"24","author":"Low","year":"2006","journal-title":"Randomized Study. JCO"},{"issue":"21","key":"10.1016\/j.ctro.2021.11.007_b0270","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.1002\/cncr.30850","volume":"123","author":"Lee","year":"2017","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ctro.2021.11.007_b0275","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1200\/JCO.2008.18.1545","article-title":"Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma","volume":"27","author":"Hui","year":"2009","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.ctro.2021.11.007_b0280","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1002\/cncr.28049","volume":"119","author":"Chen","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.ctro.2021.11.007_b0285","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ejca.2018.10.020","article-title":"Ten-year outcomes of survival and toxicity for a phase III randomised trial of concurrent chemoradiotherapy versus radiotherapy alone in stage II nasopharyngeal carcinoma","volume":"110","author":"Li","year":"2019","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ctro.2021.11.007_b0290","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejca.2019.07.007","article-title":"Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trial","volume":"119","author":"Yang","year":"2019","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ctro.2021.11.007_b0295","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ijc.32099","article-title":"Concurrent chemoradiotherapy with\/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Long-term results of phase 3 randomized controlled trial","volume":"145","author":"Li","year":"2019","journal-title":"Int J Cancer"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630821000987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630821000987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:09:22Z","timestamp":1762502962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630821000987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":59,"alternative-id":["S2405630821000987"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2021.11.007","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meta-analysis of chemotherapy in nasopharynx carcinoma (MAC-NPC): An update on 26 trials and 7080 patients","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2021.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}]}}